Format

Send to

Choose Destination
Curr Diab Rep. 2018 Jan 30;18(1):4. doi: 10.1007/s11892-018-0973-9.

Emerging Technologies for the Management of Type 1 Diabetes in Pregnancy.

Author information

1
Department of Medicine, Division of Endocrinology and Metabolism, University of Calgary, Calgary, AB, Canada.
2
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. helen.murphy@uea.ac.uk.
3
Women's Health Academic Centre, Division of Women's and Children's Health, King's College London, London, UK. helen.murphy@uea.ac.uk.
4
Norwich Medical School, University of East Anglia, Floor 2, Bob Champion Research and Education Building, James Watson Road, Norwich Research Park, Norwich, NR4 7UQ, UK. helen.murphy@uea.ac.uk.

Abstract

PURPOSE OF REVIEW:

The purpose of the study is to discuss emerging technologies available in the management of type 1 diabetes in pregnancy.

RECENT FINDINGS:

The latest evidence suggests that continuous glucose monitoring (CGM) should be offered to all women on intensive insulin therapy in early pregnancy. Studies have additionally demonstrated the ability of CGM to help gain insight into specific glucose profiles as they relate to glycaemic targets and pregnancy outcomes. Despite new studies comparing insulin pump therapy to multiple daily injections, its effectiveness in improving glucose and pregnancy outcomes remains unclear. Sensor-integrated insulin delivery (also called artificial pancreas or closed-loop insulin delivery) in pregnancy has been demonstrated to improve time in target and performs well despite the changing insulin demands of pregnancy. Emerging technologies show promise in the management of type 1 diabetes in pregnancy; however, research must continue to keep up as technology advances. Further research is needed to clarify the role technology can play in optimising glucose control before and during pregnancy as well as to understand which women are candidates for sensor-integrated insulin delivery.

KEYWORDS:

Artificial pancreas; Closed loop; Continuous glucose monitoring; Diabetes in pregnancy; Insulin pump; Technology

PMID:
29383544
PMCID:
PMC5790845
DOI:
10.1007/s11892-018-0973-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center